Medications that target obesity are not typically covered by Medicare. When the FDA approved semaglutide as a way to treat certain cardiovascular risks, however, CMS said Medicare coverage was on the table. 

“This instability is putting in jeopardy our collective ability to meet the core objective of the No Surprises Act: to protect patients," ACR and others wrote recently. 

The company has entered into a definitive agreement to purchase Core Ventures, resulting in the Florida Cancer Specialists & Research Institute aligning with its oncology network.

Congress is considering two bills that would prevent or mitigate the Medicare physician payment cuts that went into effect in January 2024, and the Society for Cardiovascular Angiography and Interventions is urging members write their Congressmen.

UPDATED: Private equity-backed groups such as Rad Partners have dominated IDR use, with "little evidence" rank-and-file radiologists are using the system, experts wrote in Health Affairs. 

Despite amassing a wait list of 10,000 individuals, the company has confronted “significant barriers due to restrictions on private imaging services in Ontario.” 

CMS wants feedback after proposing a significant update to CCTA reimbursement payments. The American College of Cardiology, a longtime champion for improved cardiac CT payments, is now helping its members make their voices heard.

Evolent is attracting interest from buyers, and a sale of the company could be finalized in weeks, sources claim.